Molecular genetics of intraductal papillary–mucinous neoplasms of the pancreas
Author:
- 29 May 2007
- journal article
- review article
- Published by Springer Nature in Journal of Hepato-Biliary-Pancreatic Surgery
- Vol. 14 (3) , 233-237
Abstract
Intraductal papillary–mucinous neoplasms of the pancreas show characteristic clinicopathological and molecular pathobiological features which are distinct from those of conventional ductal adenocarcinomas. Alterations of KRAS, AKT/PKB, CDKN2A, TP53, SMAD4, STK11/LKB1, and DUSP6, and other molecular alterations, including global expression studies as well as their clinical implications, are discussed.Keywords
This publication has 40 references indexed in Scilit:
- Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus studyVirchows Archiv, 2005
- Cystic Neoplasm of the PancreasPancreas, 2004
- Intraductal Papillary Mucinous Neoplasm of the PancreasPancreas, 2004
- Comparison of K‐ras point mutation distributions in intraductal papillary‐mucinous tumors and ductal adenocarcinoma of the pancreasInternational Journal of Cancer, 2004
- Intraductal papillary‐mucinous neoplasms of the pancreasCancer, 2001
- Signaling Networks and Cell Cycle Control2000
- Intraductal Papillary Mucinous Tumors of the Pancreas Comprise 2 Clinical SubtypesArchives of Surgery, 1999
- K-ras Mutation and p53 Protein Accumulation in Intraductal Mucin-Hypersecreting Neoplasms of the PancreasPancreas, 1996
- The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mappingCancer, 1992
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988